Strating A, Bunn T O, Goff M T, Phillips C E
J Am Vet Med Assoc. 1975 Nov 1;167(9):809-12.
Inactivated, nonadjuvanted tissue culture-origin rabies vaccine was tested in 168 dogs for its ability to provide protection against challenge of immunity 1 year after vaccination. Several laboratory methods were used concurrently to measure the potency of the vaccine. When used at full strength, the vaccine protected 70% of dogs after either a 1- or 2-dose vaccination schedule. When vaccine was diluted to contain less antigenic mass, the 1-dose schedule was not as effective as 2 doses. High serum-neutralizing antibody titers developed by 7 days after vaccination, but the titers declined rapidly thereafter. The US reference vaccine protected 28 of 30 dogs.
对168只犬进行了非佐剂组织培养来源的灭活狂犬病疫苗测试,以检测其在接种疫苗1年后提供免疫保护以抵抗攻击的能力。同时使用了几种实验室方法来测量疫苗效力。按全强度使用时,无论是单剂量还是双剂量接种方案,疫苗都能保护70%的犬。当疫苗稀释以减少抗原量时,单剂量接种方案不如双剂量有效。接种疫苗7天后血清中和抗体滴度升高,但此后迅速下降。美国参比疫苗保护了30只犬中的28只。